Ypsomed Holding AG (YPSN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ypsomed Holding AG (YPSN) has a cash flow conversion efficiency ratio of 0.162x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF130.38 Million ≈ $164.83 Million USD) by net assets (CHF807.19 Million ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See YPSN net asset quality index to measure how much of total assets are equity-financed.
Ypsomed Holding AG - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how Ypsomed Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Ypsomed Holding AG to evaluate the quality of earnings relative to operating cash generation.
Ypsomed Holding AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ypsomed Holding AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Patterson-UTI Energy Inc
NASDAQ:PTEN
|
0.020x |
|
Lazard Ltd
NYSE:LAZ
|
0.291x |
|
TRI Pointe Homes Inc
NYSE:TPH
|
0.067x |
|
Vontobel Holding
SW:VONN
|
0.544x |
|
KRONES AG(UNSP.ADR)1/2/ON
F:KRNU
|
0.035x |
|
Sinotruk Jinan Truck Co Ltd
SHE:000951
|
0.125x |
|
Jiangsu Aucksun Co Ltd
SHE:002245
|
0.036x |
|
Jiangxi Zhengbang Technology Co Ltd
SHE:002157
|
0.025x |
Annual Cash Flow Conversion Efficiency for Ypsomed Holding AG (2002–2025)
The table below shows the annual cash flow conversion efficiency of Ypsomed Holding AG from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Ypsomed Holding AG market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | CHF679.68 Million ≈ $859.31 Million |
CHF148.20 Million ≈ $187.36 Million |
0.218x | -17.48% |
| 2024-03-31 | CHF617.73 Million ≈ $780.98 Million |
CHF163.22 Million ≈ $206.36 Million |
0.264x | +14.71% |
| 2023-03-31 | CHF562.33 Million ≈ $710.94 Million |
CHF129.53 Million ≈ $163.76 Million |
0.230x | +5.50% |
| 2022-03-31 | CHF392.54 Million ≈ $496.28 Million |
CHF85.71 Million ≈ $108.36 Million |
0.218x | +0.58% |
| 2021-03-31 | CHF395.38 Million ≈ $499.87 Million |
CHF85.83 Million ≈ $108.51 Million |
0.217x | +70.40% |
| 2020-03-31 | CHF385.35 Million ≈ $487.18 Million |
CHF49.09 Million ≈ $62.06 Million |
0.127x | -19.38% |
| 2019-03-31 | CHF378.80 Million ≈ $478.91 Million |
CHF59.86 Million ≈ $75.68 Million |
0.158x | +1.32% |
| 2018-03-31 | CHF341.54 Million ≈ $431.80 Million |
CHF53.27 Million ≈ $67.35 Million |
0.156x | -37.29% |
| 2017-03-31 | CHF301.80 Million ≈ $381.55 Million |
CHF75.06 Million ≈ $94.90 Million |
0.249x | -13.13% |
| 2016-03-31 | CHF267.84 Million ≈ $338.62 Million |
CHF76.69 Million ≈ $96.95 Million |
0.286x | +66.50% |
| 2015-03-31 | CHF240.64 Million ≈ $304.23 Million |
CHF41.38 Million ≈ $52.32 Million |
0.172x | -4.78% |
| 2014-03-31 | CHF228.16 Million ≈ $288.46 Million |
CHF41.21 Million ≈ $52.10 Million |
0.181x | +158.82% |
| 2013-03-31 | CHF217.37 Million ≈ $274.82 Million |
CHF15.17 Million ≈ $19.18 Million |
0.070x | -51.02% |
| 2012-03-31 | CHF218.00 Million ≈ $275.61 Million |
CHF31.05 Million ≈ $39.26 Million |
0.142x | +159.79% |
| 2011-03-31 | CHF538.06 Million ≈ $680.25 Million |
CHF29.50 Million ≈ $37.30 Million |
0.055x | +31.17% |
| 2010-03-31 | CHF537.74 Million ≈ $679.85 Million |
CHF22.48 Million ≈ $28.42 Million |
0.042x | -62.26% |
| 2009-03-31 | CHF437.03 Million ≈ $552.53 Million |
CHF48.40 Million ≈ $61.20 Million |
0.111x | -34.08% |
| 2008-03-31 | CHF417.58 Million ≈ $527.93 Million |
CHF70.16 Million ≈ $88.69 Million |
0.168x | +111.65% |
| 2007-03-31 | CHF390.03 Million ≈ $493.10 Million |
CHF30.96 Million ≈ $39.14 Million |
0.079x | -30.83% |
| 2006-03-31 | CHF404.01 Million ≈ $510.78 Million |
CHF46.37 Million ≈ $58.62 Million |
0.115x | -56.75% |
| 2005-03-31 | CHF357.17 Million ≈ $451.56 Million |
CHF94.78 Million ≈ $119.82 Million |
0.265x | -88.16% |
| 2004-03-31 | CHF11.84 Million ≈ $14.97 Million |
CHF26.54 Million ≈ $33.55 Million |
2.241x | +1127.06% |
| 2003-03-31 | CHF111.68 Million ≈ $141.20 Million |
CHF20.40 Million ≈ $25.79 Million |
0.183x | +168.73% |
| 2002-03-31 | CHF95.58 Million ≈ $120.84 Million |
CHF6.50 Million ≈ $8.21 Million |
0.068x | -- |
About Ypsomed Holding AG
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable inje… Read more